Several Indian pharmaceutical companies are ushering in the next generation of their promoter families to take over the reins ...

Hims & Hers (HIMS) doubles revenue, expands margins, and grows subscribers. Zava acquisition triples market potential, ...

Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies into the clinic.

The Philippine National Police (PNP) will see to it that high-profile individuals evading the law are apprehended even if it ...

The vaunted House quad-committee (quad-comm) may have one final surprise before it concludes its series of hearings on Monday ...

Many patients with ER-positive/HER2-negative advanced breast cancer eventually develop resistance to standard first-line ...

Prom Queen," Netflix's first stab at adaption the R.L. Stine series since a high-profile film trilogy in 2021, is ...

Vepdegestrant, an investigational estrogen receptor (ER) degrader, known as a proteolysis-targeting chimera (PROTAC ), ...

The Spinocerebellar Ataxia pipeline is advancing fast as troriluzole nears FDA nod and rivals race with gene and stem cell therapies to seize market edge. Disease modification in spinocerebellar ...

Bernstein’s 41st Annual Strategic Decisions Conference Call May 28, 2025 9:00 AM ETCompany ParticipantsJoaquin Duato ...

Giorgio Armani's long and extraordinarily prolific career is characterised by stylistic coherence‭, ‬which continues to distinguish itself in t ...

NatWest Group PLC, Pernod Ricard SA, Novo Nordisk A/S Class B, Software AG. Read 's Market Analysis on Investing.com UK.